| 000 | 00000nam 2200000zi 4500 |
| 001 | 9.954283 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20251202101259 |
|---|
| 006 | m o d f |
|---|
| 007 | cr mn||||||||| |
|---|
| 008 | 250820t20252025onca o f000 0 eng d |
|---|
| 020 | |a9780660785547 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aH82-19/2025E-PDF |
|---|
| 245 | 00|aPatented Medicine Prices Review Board : |b2026-2030 strategic plan. |
|---|
| 264 | 1|aOttawa, Ontario : |bPatented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, |c[2025] |
|---|
| 264 | 4|c©2025 |
|---|
| 300 | |a1 online resource (13 pages) : illustrations |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Conseil d'examen du prix des médicaments brevetés : plan stratégique 2026-2030. |
|---|
| 500 | |a"Towards a bright and productive future." |
|---|
| 610 | 10|aCanada. |bPatented Medicine Prices Review Board|xPlanning. |
|---|
| 650 | 0|aStrategic planning|zCanada. |
|---|
| 710 | 1 |aCanada. |bPatented Medicine Prices Review Board, |eissuing body. |
|---|
| 775 | 08|tConseil d'examen du prix des médicaments brevetés : |w(CaOODSP)9.954287 |
|---|
| 795 | |tStrategic plan 2015–2018 |w(CaOODSP)9.802211 |
|---|
| 856 | 40|qPDF|s36.40 MB|uhttps://publications.gc.ca/collections/collection_2025/cepmb-pmprb/H82-19-2025-eng.pdf |
|---|
| 856 | 4 |qHTML|sN/A|uhttps://www.canada.ca/en/patented-medicine-prices-review/corporate/transparency/strategic-plan/2026-2030.html |
|---|